Fresenius Medical Care AG (FMCQF) Shares Outstanding (Weighted Average) (2016 - 2025)
Fresenius Medical Care AG has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $339.0 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $339.0 million for Q4 2025, up 8.11% from a year ago — trailing twelve months through Dec 2025 was $339.0 million (up 8.11% YoY), and the annual figure for FY2025 was $339.0 million, up 8.11%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $339.0 million at Fresenius Medical Care AG, up from $313.5 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for FMCQF hit a ceiling of $339.0 million in Q4 2025 and a floor of $299.2 million in Q4 2022.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $315.7 million (2023), compared with a mean of $320.5 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 10.72% in 2022 and later rose 8.11% in 2025.
- Fresenius Medical Care AG's Shares Outstanding (Weighted Average) stood at $335.1 million in 2021, then dropped by 10.72% to $299.2 million in 2022, then rose by 5.52% to $315.7 million in 2023, then fell by 0.68% to $313.5 million in 2024, then rose by 8.11% to $339.0 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $339.0 million (Q4 2025), $313.5 million (Q4 2024), and $315.7 million (Q4 2023) per Business Quant data.